Cargando…
Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors
The design and evaluation of a novel decahydroisoquinolin scaffold as an inhibitor for severe acute respiratory syndrome (SARS) chymotrypsin-like protease (3CL(pro)) are described. Focusing on hydrophobic interactions at the S(2) site, the decahydroisoquinolin scaffold was designed by connecting the...
Autores principales: | Shimamoto, Yasuhiro, Hattori, Yasunao, Kobayashi, Kazuya, Teruya, Kenta, Sanjoh, Akira, Nakagawa, Atsushi, Yamashita, Eiki, Akaji, Kenichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111320/ https://www.ncbi.nlm.nih.gov/pubmed/25614110 http://dx.doi.org/10.1016/j.bmc.2014.12.028 |
Ejemplares similares
-
Evaluation of a non-prime site substituent and warheads combined with a decahydroisoquinolin scaffold as a SARS 3CL protease inhibitor
por: Ohnishi, Kouji, et al.
Publicado: (2019) -
Evaluation of an octahydroisochromene scaffold used as a novel SARS 3CL protease inhibitor
por: Yoshizawa, Shin-ichiro, et al.
Publicado: (2020) -
The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease
por: Awahara, Chiyuki, et al.
Publicado: (2022) -
Synthesis and evaluation of phenylisoserine derivatives for the SARS-CoV 3CL protease inhibitor
por: Konno, Hiroyuki, et al.
Publicado: (2017) -
Design and synthesis of a series of serine derivatives as small molecule inhibitors of the SARS coronavirus 3CL protease
por: Konno, Hiroyuki, et al.
Publicado: (2016)